-
Real Madrid fan group wants Mbappe apology over Ceuta shirt snub
-
Germany urges EU action against China to defend carmakers
-
Nepal floods among 'most challenging' disasters: WFP
-
Stocks mostly rise after US Fed rate hike, oil eases
-
Doubts as Italy eyes electric future for steel plant
-
Palestinians turn rugged caves into homes after Israeli demolitions
-
'One of the kindest people': Taraneh, 21, facing execution in Iran
-
Two unseen Monet paintings to be sold in Paris: auction house
-
Japan eyes changing prostitution law to punish sex buyers
-
Klopp wants German team to help reclaim national pride from far-right
-
After record rain, typhoon threatens new challenge to Asian Games
-
Ninth woman found dead in South Africa killing spree
-
Kids and social media: what would change under new EU law
-
Smog scuppers Japan force helping fight Indonesia wildfires
-
Modi pitches India as global chipmaking hub
-
King Charles to call on tech giants for 'reassurances' over AI
-
Ukraine plans record defence spending in 2027
-
Lebanon security talks in Paris focus on replacing UN mission
-
Klopp calls up 44 players in huge first Germany squad
-
Most stocks rise as Fed hikes and oil prices drop
-
STARPRIME Responds to Diverging Gold Market Demand with AM/PM Fixing and XAU24/7
-
'Vande Mataram': Why is India's freedom song in spotlight?
-
Ukrainian fashion designer debuts art between air raids
-
Counterculture pop artist Peter Max dies at 88: US media
-
Gambian businesses struggle under prolonged blackouts
-
Asian Games chief defends 'functional' rooms after backlash
-
Fiji declares national HIV crisis
-
Leader's sister says only 'idiots' think N. Korea to give up nukes
-
Australia to cut migration to fix housing crisis: minister
-
World's water cycle becoming more unpredictable, UN warns
-
NASA scan discovers new, 'once in a century' Moon crater
-
Where the US-China tariff row stands ahead of White House summit
-
Most stocks rise as Fed hikes and indicates drive to curb inflation
-
Croc-habitat gets green light for 2032 Olympic rowing
-
US again denies Palestinian leader Abbas visa to attend UN assembly
-
Indonesia cash-for-photos scheme turns animal hunters into protectors
-
Lula says he will go to UN to tell Trump to 'stay out' of Brazil's elections
-
'Left-field' life: Briton becomes Thailand's top foreign monk
-
Messi heads Inter Miami to Campeones Cup triumph
-
India's transgender amendment leaves many in limbo
-
AI looms large ahead of Xi, Trump summit
-
Trump to host Xi amid pomp, low expectations
-
Smith still haunted by 'Sandpapergate' as he prepares for South Africa Tests
-
Harry set for UK public outings with security, royal status hazy
-
UK-Sudanese author pens book to give children 'African history of Africa'
-
NFL Chiefs' Kelce among investors bilked in Ponzi scheme
-
Boehly and Walter sell Chelsea stake to Clearlake Capital
-
Webinar for Emerging Spirit Brands and Investors Seeking Nationwide Distribution and Direct-to-Consumer Growth
-
Banyan Gold Intersects 1.05 g/t Gold over 52.8 metres and Bonanza-Grade Gold at Powerline Deposit, AurMac, Yukon, Canada
-
Siren's Tale French Vodka Wins Gold at the 2026 San Diego Spirits Festival International Bottle Competition
Moderna to Present at Upcoming Conferences in September 2026
CAMBRIDGE, MA / ACCESS Newswire / September 1, 2026 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conferences:
Morgan Stanley 24th Annual Global Healthcare Conference, on Monday, September 14 at 10:00 a.m. ET
Bernstein Insights: Healthcare Leaders and Disruptors 3rd Annual Healthcare Forum, on Wednesday, September 23at 8:50 a.m. ET
A live webcast of each of these presentations will be available under "Events and Presentations" in the Investors section of the Moderna website at investors.modernatx.com.
A replay of each webcast will be archived on Moderna's website for at least 30 days following the presentation.
About Moderna
Moderna is a pioneer and leader in the field of mRNA medicine. Through the advancement of its technology platform, Moderna is reimagining how medicines are made to transform how we treat and prevent diseases. Since its founding, Moderna's mRNA platform has enabled the development of vaccines and therapeutics across infectious diseases, cancer, rare diseases and more.
With a global team and a unique culture, driven by the company's values and mindsets, Moderna's mission is to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X, Facebook, Instagram, YouTube and LinkedIn.
Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
[email protected]
SOURCE: Moderna, Inc.
View the original press release on ACCESS Newswire
N.Walker--AT